Literature DB >> 1249520

Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.

R J North, D P Kirstein, R L Tuttle.   

Abstract

The subcutaneous injection of cells of any one of five unselected murine tumors resulted very rapidly in the liberation into the circulation of a small molecular weight factor that severely impaired the capacity of the host to resist experimental infection with Listeria monocytogenes and Yersinia enterocolitica. It was found that the factor appeared in blood within 8 h of injecting tumor cells subcutaneously. That it possessed potent physiological activity was evidenced by the demonstration that an infusion of as little as 0.015 ml of tumor-bearer serum strikingly suppressed the capacity of normal recipients to resist bacterial infection. It was reasoned on the basis of the knowledge that the only cells in mice with the capacity to destroy Listeria are macrophages, that suppression of antibacterial resistance was caused by the ability of the tumor-suppressor factor to interfere, either directly or indirectly, with the antibacterial functions of these mononuclear phagocytic cells. The results are consistent with the hypothesis that at least some malignant neoplastic cells are naturally selected to avoid destruction by native and acquired antitumor mechanisms of mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249520      PMCID: PMC2190133          DOI: 10.1084/jem.143.3.559

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

Review 1.  IMMUNOLOGY OF EXPERIMENTAL TUMORS.

Authors:  L J OLD; E A BOYSE
Journal:  Annu Rev Med       Date:  1964       Impact factor: 13.739

2.  Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors.

Authors:  R Keller
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

3.  Nature of "memory" in T-cell mediated antibacterial immunity: cellular parameters that distinguish between the active immune response and a state of "memory".

Authors:  R J North; J F Deissler
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

4.  Prostaglandins, calcium metabolism and cancer.

Authors:  A H Tashjian; E F Voelkel; P Goldhaber; L Levine
Journal:  Fed Proc       Date:  1974-01

Review 5.  Immunodeficiency and cancer.

Authors:  J H Kersey; B D Spector; R A Good
Journal:  Adv Cancer Res       Date:  1973       Impact factor: 6.242

6.  Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum.

Authors:  R L Tuttle; R J North
Journal:  J Natl Cancer Inst       Date:  1975-12       Impact factor: 13.506

7.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

8.  T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis.

Authors:  R J North
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

9.  Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production.

Authors:  R J North
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

10.  Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages.

Authors:  R Keller
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  29 in total

1.  Effects of L2C leukemia on macrophage-mediated responses.

Authors:  D P Collins
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.

Authors:  S Tsuru; K Nomoto; M Taniguchi; H Fujisawa; Y Zinnaka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 3.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

4.  Isolation of tumor-secreted products from human carcinoma cells maintained in a defined protein-free medium.

Authors:  E M Alderman; R R Lobb; J W Fett
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

Review 5.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

6.  Tumour-associated inhibition of immediate hypersensitivity reactions in mice.

Authors:  N R Lynch; J C Salomon
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

7.  Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.

Authors:  H Miyata; K Himeno; S Miake; K Nomoto
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

8.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

9.  Effect of L1210 leukemia on the susceptibility of mice to Candida albicans infections.

Authors:  J A Johnson; B H Lau; R L Nutter; J M Slater; C E Winter
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

10.  Effect of whole-body microwave hyperthermia on delayed cutaneous hypersensitivity in tumor-bearing mice.

Authors:  W Roszkowski; J M Wrembel; K Roszkowski; M Janiak; S Szmigielski
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.